MPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumor

Basit Öğe Kaydı
dc.authoridCOSKUN, Ebru INCI/0000-0003-4402-3725
dc.authoridCiplak, Baris/0000-0002-9981-9264
dc.authorwosidEkici, Kemal/AAF-6505-2022
dc.authorwosidCOSKUN, Ebru INCI/ABI-8238-2020
dc.authorwosidEkici, Kemal/AFJ-9488-2022
dc.authorwosidCiplak, Baris/AAB-2086-2021
dc.contributor.authorYilmaz, E.
dc.contributor.authorCoskun, E. I.
dc.contributor.authorSahin, N.
dc.contributor.authorCiplak, B.
dc.contributor.authorEkici, K.
dc.date.accessioned2024-08-04T20:44:08Z
dc.date.available2024-08-04T20:44:08Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: Evaluation of mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), and platelet count in the detection of malignant and benign ovarian tumors. Material and Methods: Sixty-six patients admitted to the present clinic over three years were included in the study. Patients diagnosed with ovarian cancer were grouped into the areas of epithelial and granulosa cell tumor diagnosis. The values were compared to patients with benign cystic structure. Patients' preoperative hematologic parameters and their values four weeks postoperatively were analyzed. Statistical analyses were performed with SPSS software. Results: MPV, NLR, and platelet count were observed at a higher rate as statistically significant in patients diagnosed with malignant ovarian cancer, compared to those with benign adnexal mass. Conclusion: The hematological parameters such as MPV, NLR, and platelet count in the detection of malignant ovarian tumors have been evaluated as useful new markers.en_US
dc.identifier.doi10.12892/ejgo3423.2017
dc.identifier.endpage349en_US
dc.identifier.issn0392-2936
dc.identifier.issue3en_US
dc.identifier.pmid29693870en_US
dc.identifier.scopus2-s2.0-85037034402en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage346en_US
dc.identifier.urihttps://doi.org/10.12892/ejgo3423.2017
dc.identifier.urihttps://hdl.handle.net/11616/98055
dc.identifier.volume38en_US
dc.identifier.wosWOS:000401497500003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherI R O G Canada, Incen_US
dc.relation.ispartofEuropean Journal of Gynaecological Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMalignanten_US
dc.subjectMPVen_US
dc.subjectNLRen_US
dc.subjectOvarian tumorsen_US
dc.titleMPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumoren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu